Search results
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoTeva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript November 8, 2023...
Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit
Benzinga via Yahoo Finance· 12 months agoTeva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic...
TEVA Shares Rise on Broad Support for Opioids Settlement
Zacks via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Limited TEVA announced that a sufficient number of states and local...
Why Teva Pharmaceutical Stock Is Jumping Today
Motley Fool· 1 year agoShares of Teva Pharmaceutical Industries (NYSE: TEVA) were jumping 5.7% as of 11:21 a.m. ET on Thursday. Francis maintained that focusing on these four...
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges
CNN Business via AOL· 10 months agoTeva Pharmaceuticals agreed to pay more than $200 million in fines and divest a key generic drug...
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO
Reuters via Yahoo News· 4 months agoTEL AVIV (Reuters) -Teva Pharmaceutical Industries will remain a single company for generic and...
Teva Leans Into Sanofi's 'Pipeline-In-A-Product' Expertise In $1.5 Billion Deal
Investor's Business Daily· 9 months agoTeva stock dipped Wednesday after the company announced it would partner with Sanofi to develop a...
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Reuters via Yahoo Finance· 2 years agoTeva Pharmaceutical Industries expects to finalise an opioid settlement in the United States by...
Why Teva Stock Shot More Than 3% Higher Today
Motley Fool· 2 years agoTeva Pharmaceutical Industries (NYSE: TEVA) stock closed the trading week in style, rising by over 3% on a bleak and bearish day for the wider market....
Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling
Investor's Business Daily· 1 year agoTeva Pharmaceutical said Monday it plans a competing knockoff of Axsome Therapeutics' new depression...